Clinical trial
Post Marketing Study of the GORE VIABAHN Endoprosthesis With Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery Obstructive Disease (VIPER)
NCT00541307 is registered in ClinicalTrials.gov with W.L.Gore & Associates as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post Marketing Study of the GORE VIABAHN Endoprosthesis With Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery Obstructive Disease (VIPER)
- Lead sponsor
- W.L.Gore & Associates
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2007
- Completion date
- June 30, 2011
- Enrollment
- 119 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.